Meklēt instrumentus
BioNTech SE
BioNTech SE is a leading German biotechnology company that specializes in developing personalized immunotherapies for the treatment of cancer and other serious diseases. The company's innovative approach involves using messenger RNA (mRNA) to stimulate the immune system to attack cancer cells, which has the potential to revolutionize cancer treatment by providing a highly targeted and effective therapy that is tailored to each patient's individual genetic makeup. BioNTech is also developing mRNA-based vaccines for infectious diseases, including COVID-19. The company has established partnerships with several pharmaceutical companies and academic institutions to advance its research and bring its therapies to market. BioNTech is dedicated to improving the lives of patients through cutting-edge science and innovation.Instrument specification in OANDA
Name
Currency
Simbols
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN
Sāciet tirgot tagad ar ātru konta atvēršanu.
Reģistrējieties tagad, lai tirgotos aktīvākajos tirgos
ATVER KONTU
OANDA ir vairāk nekā 20 gadus tirgū strādājošs brokeris, kas lepojas ar vadošajiem analīzes rīkiem un tūkstošiem apmierinātu klientu, un ir godalgots starpnieks.
Iegūstiet piekļuvi visaktīvākajiem pasaules tirgiem ar tūkstošiem tirdzniecības instrumentu, kā arī vadošajiem tehniskajiem rīkiem, kas palīdz veikt analīzi.
Tirdzniecība bez liekām izmaksām un pilnīga cenu pārredzamība - OANDA piedāvā nulles komisijas maksu par galvenajiem instrumentiem un pārredzamu cenu noteikšanu.
